Seres Therapeutics (MCRB) PT Lowered to $4 at Oppenheimer
Tweet Send to a Friend
(Updated - May 9, 2024 4:34 AM EDT)
Oppenheimer analyst Jeff Jones lowered the price target on Seres Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones lowered the price target on Seres Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
